Eric Powers to Coronary Artery Disease
This is a "connection" page, showing publications Eric Powers has written about Coronary Artery Disease.
Connection Strength
1.228
-
Drug-Eluting Stents or Bypass Surgery for?Left Main Disease: The Impact of Diabetes Mellitus. J Am Heart Assoc. 2020 04 21; 9(8):e016457.
Score: 0.446
-
Comparison of lipid deposition at coronary bifurcations versus at nonbifurcation portions of coronary arteries as determined by near-infrared spectroscopy. Am J Cardiol. 2013 Aug 01; 112(3):369-72.
Score: 0.275
-
Prevalence of unfavorable angiographic characteristics for percutaneous intervention in patients with unprotected left main coronary artery disease. Catheter Cardiovasc Interv. 2006 Sep; 68(3):357-62.
Score: 0.173
-
Predicting future left anterior descending artery events from non-culprit lesions: insights from the Lipid-Rich Plaque study. Eur Heart J Cardiovasc Imaging. 2022 09 10; 23(10):1365-1372.
Score: 0.132
-
2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques. J Am Coll Cardiol. 2020 03 31; 75(12):1371-1382.
Score: 0.111
-
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial. Circulation. 2002 May 21; 105(20):2347-54.
Score: 0.032
-
Fractional flow reserve compared with intravascular ultrasound guidance for optimizing stent deployment. Circulation. 2001 Oct 16; 104(16):1917-22.
Score: 0.031
-
Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study. Lancet. 2019 11 02; 394(10209):1629-1637.
Score: 0.027